RAB8B Activators comprises a group of compounds and molecules that have shown the capability to directly or indirectly influence the activation state of the RAB8B protein within cellular contexts. RAB8B is a member of the RAS oncogene family, playing a vital role in intracellular vesicle trafficking and membrane dynamics. It serves as a molecular switch, cycling between its active GTP-bound form and the inactive GDP-bound state, and this transition is intricately linked to its function within various cellular processes. RAB8B activators are substances that promote the activation of RAB8B, often by facilitating the exchange of GDP for GTP or by modulating the regulatory pathways associated with its activation.
These activators act as molecular switches themselves, as they trigger or enhance the activation of RAB8B, facilitating its involvement in crucial intracellular processes. While the specific chemicals that fall under the category of RAB8B Activators may vary, they generally play a pivotal role in regulating vesicle trafficking, organelle maintenance, and membrane fusion within the cell. By directly or indirectly promoting RAB8B activation, these compounds contribute to the precise coordination of vesicle transport, aiding in the delivery of proteins, lipids, and other essential cargo to their intended destinations. Understanding the mechanisms and compounds that fall under the class of RAB8B Activators is fundamental to unraveling the intricacies of intracellular transport and membrane dynamics, shedding light on the complex web of regulatory processes that govern the inner workings of eukaryotic cells.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Promotes changes in nuclear export and vesicle trafficking processes, leading to the activation of RAB8B and contributing to cellular regulation. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Indirectly activates RAB8B by disrupting the Golgi apparatus and vesicle trafficking, resulting in changes in RAB8B's activation state and related processes. | ||||||